Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.86B |
| 2 |
Exxon Mobil
XOM
|
+$1.35B |
| 3 |
Apple
AAPL
|
+$1.19B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Amazon
AMZN
|
+$1.06B |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.24B |
| 2 |
GE Aerospace
GE
|
+$712M |
| 3 |
Broadcom
AVGO
|
+$499M |
| 4 |
Apollo Global Management
APO
|
+$286M |
| 5 |
Super Micro Computer
SMCI
|
+$243M |
Sector Composition
| 1 | Technology | 31.9% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 11.66% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Benitec Biopharma
BNTC
$350M
| $447K | ﹤0.01% |
63,975
+53,951
| +538% | +$377K |
|
3602
Grifois
GRFS
$6.7B
| $446K | ﹤0.01% |
70,799
-54,428
| -43% | -$343K |
|
3603
Research Solutions
RSSS
$108M
| $446K | ﹤0.01% |
174,878
+12,640
| +8% | +$32.2K |
|
3604
Playboy, Inc. Common Stock
PLBY
$197M
| $444K | ﹤0.01% |
571,149
+16,435
| +3% | +$12.8K |
|
3605
Celularity
CELU
$62.7M
| $443K | ﹤0.01% |
141,555
+6,912
| +5% | +$21.6K |
|
3606
Crown Crafts
CRWS
$31.7M
| $442K | ﹤0.01% |
84,492
-2,471
| -3% | -$12.9K |
|
3607
Genelux
GNLX
$138M
| $441K | ﹤0.01% |
226,306
-197,959
| -47% | -$386K |
|
3608
Annovis Bio
ANVS
$45M
| $439K | ﹤0.01% |
76,233
+5,442
| +8% | +$31.4K |
|
3609
Curis
CRIS
$22.4M
| $439K | ﹤0.01% |
63,577
+1,278
| +2% | +$8.82K |
|
|
AUGX
3610
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $439K | ﹤0.01% |
498,436
+67,671
| +16% | +$59.6K |
|
3611
Lipocine
LPCN
$16.3M
| $438K | ﹤0.01% |
53,179
+4,325
| +9% | +$35.6K |
|
3612
Apyx Medical
APYX
$74.5M
| $438K | ﹤0.01% |
326,445
+10,576
| +3% | +$14.2K |
|
|
STRR
3613
Star Equity Holdings, Inc. Common Stock
STRR
$34.6M
| $437K | ﹤0.01% |
26,309
+1,165
| +5% | +$19.4K |
|
3614
LENSAR
LNSR
$145M
| $437K | ﹤0.01% |
97,008
+6,297
| +7% | +$28.3K |
|
3615
Bioceres Crop Solutions
BIOX
$124M
| $436K | ﹤0.01% |
38,927
| – | – |
|
3616
BuzzFeed
BZFD
$70M
| $436K | ﹤0.01% |
158,055
+28,073
| +22% | +$77.5K |
|
3617
Sono-Tek
SOTK
$64.6M
| $435K | ﹤0.01% |
112,455
+6,554
| +6% | +$25.4K |
|
3618
CDT Equity Inc. Common Stock
CDT
$1.86M
| $434K | ﹤0.01% |
273
+180
| +194% | +$286K |
|
|
BCYC
3619
Bicycle Therapeutics
BCYC
$485M
| $433K | ﹤0.01% |
21,377
| – | – |
|
|
VOXX
3620
DELISTED
VOXX International Corporation Class A
VOXX
| $431K | ﹤0.01% |
136,508
-127,798
| -48% | -$404K |
|
3621
Carisma Therapeutics
CARM
$16.4M
| $431K | ﹤0.01% |
283,408
-245,181
| -46% | -$373K |
|
3622
First US Bancshares
FUSB
$66.9M
| $429K | ﹤0.01% |
46,388
+953
| +2% | +$8.82K |
|
|
BOLD
3623
Boundless Bio
BOLD
$26M
| $428K | ﹤0.01% |
+110,634
| New | +$428K |
|
|
RENT
3624
Rent the Runway
RENT
$25M
| $427K | ﹤0.01% |
24,308
-30,446
| -56% | -$535K |
|
3625
Lightpath Technologies
LPTH
$227M
| $426K | ﹤0.01% |
337,824
-9,781
| -3% | -$12.3K |
|